Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Journal: Science (New York, N.Y.)
Published: June 28, 2019
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.
Journal: Molecular cancer
Published: December 07, 2016
Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.
Journal: Scientific reports
Published: September 30, 2014
The Ludwig institute for cancer research Melbourne melanoma cell line panel.
Journal: Pigment cell & melanoma research
Published: March 27, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026